HomeBUSINESS
BUSINESS

Takeda Links with Swedish, Canadian Organizations on IBD Research
(Oct.2.2017)

Takeda Pharmaceutical said on September 29 that it has entered into a joint research agreement with Sweden’s medical research center Karolinska Institutet and Canada’s private-public partnership Structural Genomics Consortium to develop and validate novel therapies for the treatment of inflammatory bowel disease (IBD) ...
(LOG IN FOR FULL STORY)

News Calendar